GS
MRTX

GTS Securities’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

GTS Securities’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-47,716
Closed -$2.8M – 2232
2023
Q4 		$2.8M Buy
47,716
+1,091
+2% +$64.1K ﹤0.01% 312
2023
Q3 		$2.03M Buy
46,625
+30,451
+188% +$1.33M ﹤0.01% 323
2023
Q2 		$584K Buy
+16,174
New +$584K 0.02% 598